Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Jul 13;13(13):1515-1525.
doi: 10.1016/j.jcin.2020.04.029. Epub 2020 Jun 10.

Reoperation After Transcatheter Aortic Valve Replacement: An Analysis of the Society of Thoracic Surgeons Database

Oliver K Jawitz  1 , Brian C Gulack  2 , Maria V Grau-Sepulveda  3 , Roland A Matsouaka  3 , Michael J Mack  4 , David R Holmes Jr  5 , John D Carroll  6 , Vinod H Thourani  7 , J Matthew Brennan  8
Affiliations

Reoperation After Transcatheter Aortic Valve Replacement: An Analysis of the Society of Thoracic Surgeons Database

Oliver K Jawitz et al. JACC Cardiovasc Interv. .

Abstract

Objectives: This study sought to report the largest series of patients receiving a surgical reoperation after transcatheter aortic valve replacement (TAVR) using the Society of Thoracic Surgeons (STS) Adult Cardiac Surgery Database.

Background: TAVR has become an effective means of treating aortic stenosis. As TAVR is used in progressively lower-risk cohorts, management of device failure will become increasingly important.

Methods: The STS Adult Cardiac Surgery Database was queried for patients with a history of prior TAVR undergoing surgical aortic valve replacement from 2011 to 2015. Observed-to-expected (O/E) mortality ratios were determined to facilitate comparison across reoperative indications and timing from index TAVR procedure.

Results: A total of 123 patients met inclusion criteria (median age 77 years) with an STS Predicted Risk of Mortality of 4%, 4% to 8%, and >8% in 17%, 24%, and 59%, respectively. Median time to reoperation was 2.5 (interquartile range: 0.7 to 13.0) months, and the operative mortality rate was 17.1%. Common indications for reoperation included early TAVR device failures such as paravalvular leak (15%), structural prosthetic deterioration (11%), failed repair (11%), sizing or position issues (11%), and prosthetic valve endocarditis (10%). All pre-operative risk categories were associated with an increased O/E mortality ratio (Predicted Risk of Mortality <4%: O/E 5.5; 4% to 8%: O/E 1.7; >8%: O/E 1.2).

Conclusions: SAVR following early failure of TAVR, while rare, is associated with worse-than-expected outcomes as compared with similar patients initially undergoing SAVR. Continued experience with this developing technology is needed to reduce the incidence of early TAVR failure and further define optimal treatment of failed TAVR prostheses.

Keywords: SAVR; TAVR; device failure; surgical aortic valve replacement; transcatheter aortic valve replacement.

PubMed Disclaimer

Figures

Figure 1:
Figure 1:
Flow diagram illustrating study cohort.
Figure 2:
Figure 2:
Cumulative probability plot demonstrating variation in timing between TAVR and SAVR, among the 52 patients with this data available.
Central illustration:
Central illustration:
Flow diagram illustrating study cohort (A) and Cumulative probability plot demonstrating variation in timing between TAVR and SAVR, among the 52 patients with this data available (B)
See this image and copyright information in PMC

Comment in

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Thourani VH, Kodali S, Makkar RR, et al. Transcatheter aortic valve replacement versus surgical valve replacement in intermediate-risk patients: a propensity score analysis. Lancet. 2016;387(10034):2218–2225. - PubMed
    1. Leon MB, Smith CR, Mack M, et al. Transcatheter Aortic-Valve Implantation for Aortic Stenosis in Patients Who Cannot Undergo Surgery. New England Journal of Medicine. 2010;363(17):1597–1607. - PubMed
    1. Leon MB, Smith CR, Mack MJ, et al. Transcatheter or Surgical Aortic-Valve Replacement in Intermediate-Risk Patients. New England Journal of Medicine. 2016;374(17):1609–1620. - PubMed
    1. Latib A, Naim C, De Bonis M, et al. TAVR-associated prosthetic valve infective endocarditis: results of a large, multicenter registry. Journal of the American College of Cardiology. 2014;64(20):2176–2178. - PubMed
    1. Mylotte D, Piazza N. Transcatheter aortic valve replacement failure: deja vu ou jamais vu? Circulation Cardiovascular interventions. 2015;8(4). - PubMed

Publication types

MeSH terms